For in vitro diagnostic use. Others Elecsys AFP IVD Elecsys® AFP CPS_000431 AFP α1-fetoprotein 09 731 385 190 9 731 385 190 09731385190 9731385190 09731385190 AFP Elecsys E2G 100 V2 AFP Elecsys E2G 100 V2 07613336217146 Reagents, kits 100 tests cobas e 402/801 true 09 015 060 190 9 015 060 190 09015060190 9015060190 09015060190 AFP Elecsys cobas e 100 V2 Elecsys AFP 07613336172001 Reagents, kits 100 tests cobas e 411/601/602 true 09 015 124 190 9 015 124 190 09015124190 9015124190 09015124190 AFP Elecsys E2G 300 V2 Elecsys AFP 07613336172025 Reagents, kits 300 tests cobas e 402/801 true 09 015 086 190 9 015 086 190 09015086190 9015086190 09015086190 AFP Elecsys cobas e 200 V2 Elecsys AFP 07613336172018 Reagents, kits 200 tests cobas e 601/602 true 09015060500 Elecsys AFP en 3 FF000000062EFD0E FF00000004BD520E 09015060190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015060500 Elecsys AFP en 1 FF00000004BD520E FF0000000489570E 09015060190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015124500 Elecsys AFP en 1 FF0000000489CE0E FF0000000488A60E 09015124190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015124500 Elecsys AFP en 2 FF00000005852A0E FF0000000489CE0E 09015124190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09015086500 Elecsys AFP en 3 FF000000062F000E FF00000004BD530E 09015086190 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.This assay is intended for the use as:An aid in the diagnosis of hepatocellular carcinoma (HCC).An aid in the management of patients with non‑seminomatous germ cell tumors.One component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

User profile

Select your user profile

Elecsys^® AFP

Overview

Ordering information

Technical documents

Compatible products

Related products